香港股市 已收市

CORT Aug 2024 38.000 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
1.37000.0000 (0.00%)
收市:03:21PM EDT
全螢幕
前收市價1.3700
開市1.1000
買盤0.0000
賣出價1.3500
拍板38.00
到期日2024-08-16
今日波幅1.1000 - 1.6800
合同範圍
成交量152
未平倉合約160
  • Zacks

    Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  • Reuters

    Teva sues Corcept over mifepristone 'monopoly' for rare disorder

    Teva Pharmaceuticals sued rival drugmaker Corcept Therapeutics in federal court in San Francisco on Thursday, accusing it of monopolizing the market for mifepristone-based Korlym, used to treat a rare hormonal disorder called Cushing's syndrome. The lawsuit said Corcept and specialty pharmacy Optime Care, the sole distributor of Korlym, orchestrated “a multifaceted scheme to prolong Corcept’s monopoly by stifling competition from Teva at every turn.” Teva accused Corcept of "paying bribes and kickbacks" to physicians to keep them prescribing brand Korlym.

  • Zacks

    Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?

    Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.